EFTA00379902.pdf

From: "David Grosof on behalf of David Grosof <an To: Lesley Groff <MIMIII > Subject: Re: Mezzanine financing sought before IPO by Epiphany Biosciences -- let's talk Date: Tue, 12 Nov 2013 23:31:32 +0000 Thank you, Lesley. d At 03:08 PM 11/12/2013, you wrote: >Thanks David. Will pass along and ask if Jeffrey would like to set up a call >Sent from my iPhone >On Nov 12, 2013, at 5:57 PM, David Grosof < wrote: > Hi, Lesley, > > > As per phone message on your line, I've attached a > slide deck, with many industry a revaations/jargon, for Epiphany > Biosciences. The CEO Fred Volinsky spoke with Jeffrey back in > 2006-7, shortly after I did some consulting for it. I'd like > Jeffrey to consider investing 250K-300K on mezzanine terms that I > can sketch out but can and ought to be discussed in depth with Fred > Volinsky. I think it's a promising deal, and I'm introducing it to > another associate as well. > I'll add that the lead compound that constitutes the prime asset > of Epiphany is one I assessed with the founders in 2006, so I'm not > surprised it's progressed clinically or commercially. > > There are others being offered this mezzanine opportunity and > indications of interest by others might be happening in the next > few business days. [Fred's an aggressive salesman but I've never > caught him blowing smoke.] > > I'm reachable after 8:30 am PST (11:30 EST) Wednesday, tomorrow. > > I'd like to emphasize that I'm a huge fan of scheduling a call, > if only 20 minutes in advance, rather than get called out of the > blue while I'm, say, pumping a bicycle tire, working out, standing > in line at a drug store, etc. > Thanks for your attention... > > > Cheers, > > > > landline > > mobile > > > > > David Grosof > > > > * > > <DRAFT_Epiphany_Overview_09JUL13_v31.ppt> David Grosof EFTA00379902